Atlas Trials

Synthetic CBD as a Therapy for COVID-19

Clinical trial NCT04686539 · UNKNOWN

Trial details

NCT number
NCT04686539
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Covid19CBD
Start date
2021-01-20
Primary completion
2021-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.